Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
1.991
+0.031 (1.58%)
Nov 5, 2024, 1:15 PM EST - Market open
Aadi Bioscience Employees
Aadi Bioscience had 89 employees as of December 31, 2023. The number of employees increased by 10 or 12.66% compared to the previous year.
Employees
89
Change (1Y)
10
Growth (1Y)
12.66%
Revenue / Employee
$267,607
Profits / Employee
-$735,315
Market Cap
49.01M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 89 | 10 | 12.66% |
Dec 31, 2022 | 79 | 40 | 102.56% |
Dec 31, 2021 | 39 | 31 | 387.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Rapid Micro Biosystems | 193 |
Vicarious Surgical | 131 |
Lucid Diagnostics | 70 |
iCAD, Inc. | 69 |
OncoCyte | 46 |
LAVA Therapeutics | 37 |
Envoy Medical | 34 |
Elicio Therapeutics | 32 |
AADI News
- 5 days ago - Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update - PRNewsWire
- 2 months ago - Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates - PRNewsWire
- 3 months ago - Aadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update - PRNewsWire
- 3 months ago - Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update - PRNewsWire
- 5 months ago - Aadi Bioscience to Participate in the Jefferies Healthcare Conference - PRNewsWire
- 5 months ago - Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting - PRNewsWire
- 6 months ago - Aadi Bioscience, Inc. (AADI) Q1 2024 Earnings Call Transcript - Seeking Alpha